| scholarly article | Q13442814 |
| P50 | author | Paul R. Crocker | Q37830080 |
| P2093 | author name string | Y Yamada | |
| C Jones | |||
| N Zimmermann | |||
| B S Bochner | |||
| M E Rothenberg | |||
| M L McBride | |||
| K D Cromie | |||
| S A Hudson | |||
| P2860 | cites work | Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily | Q22011026 |
| Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome | Q24670121 | ||
| Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils | Q24678441 | ||
| Interleukin-5 priming of human eosinophils alters siglec-8 mediated apoptosis pathways | Q24685595 | ||
| A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome | Q27824793 | ||
| Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils | Q28138424 | ||
| Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis | Q28212692 | ||
| Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand | Q28257968 | ||
| Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement | Q28258592 | ||
| Siglecs--the major subfamily of I-type lectins | Q28261393 | ||
| Mechanism of Siglec-8-induced human eosinophil apoptosis: role of caspases and mitochondrial injury | Q28271835 | ||
| Eosinophilia | Q28272028 | ||
| Siglecs and their roles in the immune system | Q28294469 | ||
| Glycan array screening reveals a candidate ligand for Siglec-8 | Q28295084 | ||
| The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils | Q28505221 | ||
| Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment | Q34411053 | ||
| The FIP1L1-PDGFRA fusion gene cooperates with IL-5 to induce murine hypereosinophilic syndrome (HES)/chronic eosinophilic leukemia (CEL)-like disease | Q35848279 | ||
| Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity | Q35950210 | ||
| Pharmacological regulation of human eosinophil apoptosis | Q36230399 | ||
| Eosinophilia in transgenic mice expressing interleukin 5. | Q36353850 | ||
| Eotaxin is required for the baseline level of tissue eosinophils | Q37395472 | ||
| Immunoglobulin G: functional sites | Q39820837 | ||
| PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative disease. | Q40643306 | ||
| Molecular analysis of human Siglec-8 orthologs relevant to mouse eosinophils: identification of mouse orthologs of Siglec-5 (mSiglec-F) and Siglec-10 (mSiglec-G) | Q47442854 | ||
| Eosinophil levels in mice are significantly higher in small blood vessels than in large blood vessels. | Q53690659 | ||
| Binding of complement subcomponent Clq to mouse IgGl, IgG2a AND IgG2b: A novel Clq binding assay | Q57564256 | ||
| Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies | Q61959765 | ||
| Modulation of eosinophil chemotaxis by interleukin-5 | Q67592198 | ||
| Cytokine priming of the respiratory burst in human eosinophils is Ca2+ independent and accompanied by induction of tyrosine kinase activity | Q70682248 | ||
| Eosinophil infiltration and degranulation in normal human tissue | Q77539954 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 1156-1163 | |
| P577 | publication date | 2008-09-01 | |
| P1433 | published in | Allergy | Q2699825 |
| P1476 | title | Siglec-F antibody administration to mice selectively reduces blood and tissue eosinophils | |
| P478 | volume | 63 |
| Q36843245 | "Siglec"ting the allergic response for therapeutic targeting |
| Q35631650 | Additive anti-allergic effects of anti-interleukin-33 and anti-Siglec-F treatments in a murine model of allergic asthma |
| Q52320351 | Airway glycomic and allergic inflammatory consequences resulting from keratan sulfate galactose 6-O-sulfotransferase (CHST1) deficiency. |
| Q24645925 | Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling |
| Q37348437 | Basic and clinical immunology of Siglecs |
| Q38240474 | Biological Modulators in Eosinophilic Diseases. |
| Q37986851 | CD33-related siglecs as potential modulators of inflammatory responses |
| Q52619414 | Characterization of a novel mouse strain expressing human Siglec-8 only on eosinophils. |
| Q24608549 | Characterization of expression of glycan ligands for Siglec-F in normal mouse lungs |
| Q21284418 | Chronic OVA allergen challenged Siglec-F deficient mice have increased mucus, remodeling, and epithelial Siglec-F ligands which are up-regulated by IL-4 and IL-13 |
| Q38210619 | Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis |
| Q37431918 | Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions |
| Q35441422 | Critical role of the neutrophil-associated high-affinity receptor for IgE in the pathogenesis of experimental cerebral malaria |
| Q36811319 | Cyclophilin D regulates necrosis, but not apoptosis, of murine eosinophils |
| Q24634555 | Developmental, malignancy-related, and cross-species analysis of eosinophil, mast cell, and basophil siglec-8 expression |
| Q35266949 | Early murine T-lymphocyte activation is accompanied by a switch from N-Glycolyl- to N-acetyl-neuraminic acid and generation of ligands for siglec-E |
| Q38662897 | Emerging Roles for Eosinophils in the Tumor Microenvironment |
| Q33758139 | Eosinophil survival and apoptosis in health and disease |
| Q41874438 | Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy |
| Q38353914 | Eosinophil-selective binding and proapoptotic effect in vitro of a synthetic Siglec-8 ligand, polymeric 6'-sulfated sialyl Lewis x. |
| Q42223600 | Eosinophils are not required for the induction and maintenance of an alloantibody response |
| Q51024387 | Eosinophils are required for the maintenance of plasma cells in the bone marrow. |
| Q38234940 | Eosinophils in the lung - modulating apoptosis and efferocytosis in airway inflammation. |
| Q52948211 | Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells. |
| Q35946412 | Expression and preliminary functional analysis of Siglec-F on mouse macrophages |
| Q47281057 | FACS isolation of live mouse eosinophils at high purity via a protocol that does not target Siglec F. |
| Q90061148 | Frontline Science: Superior mouse eosinophil depletion in vivo targeting transgenic Siglec-8 instead of endogenous Siglec-F: Mechanisms and pitfalls |
| Q24622257 | Galactose 6-O-sulfotransferases are not required for the generation of Siglec-F ligands in leukocytes or lung tissue |
| Q41207923 | Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins. |
| Q35898996 | Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis |
| Q34641855 | Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". |
| Q84698017 | IL-33 Exacerbates Eosinophil-Mediated Airway Inflammation |
| Q40146282 | IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils. |
| Q36150043 | IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF |
| Q52719869 | Identification of a Siglec-F+ granulocyte-macrophage progenitor. |
| Q52851663 | Isolation of Eosinophils from the Lamina Propria of the Murine Small Intestine. |
| Q38696593 | Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells |
| Q28290873 | Mechanism of Siglec-8-mediated cell death in IL-5-activated eosinophils: role for reactive oxygen species-enhanced MEK/ERK activation |
| Q21132992 | Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1, Src kinases, NADPH oxidase or reactive oxygen |
| Q24624727 | Mice deficient in the St3gal3 gene product α2,3 sialyltransferase (ST3Gal-III) exhibit enhanced allergic eosinophilic airway inflammation |
| Q60305285 | Modulation of Immune Tolerance via Siglec-Sialic Acid Interactions |
| Q54324728 | Mouse Eosinophils: Identification, Isolation, and Functional Analysis. |
| Q35108579 | Non-invasive optical imaging of eosinophilia during the course of an experimental allergic airways disease model and in response to therapy. |
| Q34444620 | Novel targeted therapies for eosinophil-associated diseases and allergy |
| Q36763565 | Novel targeted therapies for eosinophilic disorders |
| Q38850676 | Paired Ig-like Receptor B Inhibits IL-13-Driven Eosinophil Accumulation and Activation in the Esophagus |
| Q52913728 | Phenotypic plasticity and targeting of Siglec-F(high) CD11c(low) eosinophils to the airway in a murine model of asthma. |
| Q34329191 | Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma |
| Q38676224 | Regulation of airway inflammation by Siglec-8 and Siglec-9 sialoglycan ligand expression |
| Q38256352 | Regulation of spontaneous eosinophil apoptosis-a neglected area of importance |
| Q35164415 | Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation |
| Q92399549 | Sex differences in IL-17 contribute to chronicity in male versus female urinary tract infection |
| Q37983131 | Siglec-8 and Siglec-F, the new therapeutic targets in asthma |
| Q36655884 | Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions |
| Q37343465 | Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors |
| Q37693833 | Siglec-F inhibition reduces esophageal eosinophilia and angiogenesis in a mouse model of eosinophilic esophagitis |
| Q33710652 | Siglec-F-dependent negative regulation of allergen-induced eosinophilia depends critically on the experimental model |
| Q34314957 | Siglec-mediated regulation of immune cell function in disease. |
| Q26992091 | Siglecs and immune regulation |
| Q37440061 | Siglecs as targets for therapy in immune-cell-mediated disease |
| Q38075409 | Targeting eosinophils in allergy, inflammation and beyond |
| Q90208339 | The emerging roles of eosinophils in mucosal homeostasis |
| Q35222976 | The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation. |
| Q34485066 | The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils |
| Q38598881 | Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches. |
| Q38613170 | Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives |
| Q33987218 | What targeting eosinophils has taught us about their role in diseases |
Search more.